Sign in

CIK 0001645113

  • Large accelerated filer

NovoCure Ltd

Sign in to watch
Ticker
NVCR
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Entity type
Operating
Phone
+44 1534756700
Business address
NO. 4 THE FORUM, GRENVILLE STREET, ST. HELIER, Jersey
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$142,786
in 3 filings

Net −$142,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-06-05 LEUNG GABRIEL Director Grant or award +4,053 83,192
2024-06-05 LEUNG GABRIEL Director Grant or award · Stock Option (Right to Buy) +6,229 6,229
2024-06-05 HILLEMAN JERYL L Director Grant or award +4,053 6,590
2024-06-05 HILLEMAN JERYL L Director Grant or award · Stock Option (Right to Buy) +6,229 6,229
2024-06-04 VERNON W ANTHONY Director Sale −964 $23.89 $23K 164,833
2024-06-04 Scannell Timothy J Director Sale −964 $23.89 $23K 2,964
2024-06-04 LEUNG GABRIEL Director Sale −964 $23.89 $23K 78,175
2024-03-04 GROENHUYSEN WILHELMUS CM Chief Operating Officer Sale −1,217 $16.01 $19K 251,235
2024-03-04 Leonard Frank X EVP, Pres., Novocure Oncology Sale −840 $16.01 $13K 160,098
2024-03-01 GROENHUYSEN WILHELMUS CM Chief Operating Officer Sale −2,107 $16.03 $34K 252,452
2024-03-01 Leonard Frank X EVP, Pres., Novocure Oncology Sale −1,679 $16.03 $27K 160,938
2024-02-28 Leonard Frank X EVP, Pres., Novocure Oncology Sale −2,078 $16.14 $34K 162,617
2024-02-28 GROENHUYSEN WILHELMUS CM Chief Operating Officer Sale −2,303 $16.14 $37K 254,559
2024-02-27 Cordova Ashley Chief Financial Officer Grant or award +102,249 $16.30 $1.7M 219,867
2024-02-27 Cordova Ashley Chief Financial Officer Grant or award · Stock Options (Right to buy) +156,348 $16.30 $2.5M 156,348
2024-02-27 Leonard Frank X EVP, Pres., Novocure Oncology Grant or award +102,249 $16.30 $1.7M 164,695
2024-02-27 Leonard Frank X EVP, Pres., Novocure Oncology Grant or award · Stock Options (Right to buy) +156,348 $16.30 $2.5M 156,348
2024-02-27 Puri Michal Nath Chief Human Resources Officer Grant or award +71,574 $16.30 $1.2M 109,167
2024-02-27 Puri Michal Nath Chief Human Resources Officer Grant or award · Stock Options (Right to buy) +109,443 $16.30 $1.8M 109,443
2024-02-27 Weinberg Uri Chief Innovation Officer Grant or award +81,799 $16.30 $1.3M 171,148

Page 11 of 20 · 399 trades